Fennec Pharmaceuticals Inc.FENCNASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, above historical average.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$4.80M
↑ 179% above average
Average (9y)
$-6.08M
Historical baseline
Range
High:$4.80M
Low:$-21.69M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $4.80M | +138.8% |
| 2023 | $-12.36M | +43.0% |
| 2022 | $-21.69M | -27.1% |
| 2021 | $-17.07M | - |
| 2020 | $0.00 | +100.0% |
| 2019 | $-13.07M | -2609.0% |
| 2018 | $521000.00 | +648.4% |
| 2017 | $-95000.00 | -215.9% |
| 2016 | $82000.00 | +104.3% |
| 2015 | $-1.89M | - |